Unknown

Dataset Information

0

Human Endogenous Retrovirus Reactivation: Implications for Cancer Immunotherapy.


ABSTRACT: Human endogenous retroviruses (HERVs) derive from ancestral exogenous retroviruses whose genetic material has been integrated in our germline DNA. Several lines of evidence indicate that cancer immunotherapy may benefit from HERV reactivation, which can be induced either by drugs or by cellular changes occurring in tumor cells. Indeed, several studies indicate that HERV proviral DNA can be transcribed either to double-stranded RNA (dsRNA) that is sensed as a "danger signal" by pattern recognition receptors (PRRs), leading to a viral mimicry state, or to mRNA that is translated into proteins that may contribute to the landscape of tumor-specific antigens (TSAs). Alternatively, HERV reactivation is associated with the expression of long noncoding RNAs (lncRNAs). In this review, we will highlight recent findings on HERV reactivation in cancer and its implications for cancer immunotherapy.

SUBMITTER: Petrizzo A 

PROVIDER: S-EPMC8122352 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6441874 | biostudies-literature
| S-EPMC341815 | biostudies-literature
| S-EPMC10348765 | biostudies-literature
| S-EPMC136318 | biostudies-literature
| S-EPMC1781480 | biostudies-literature
| S-EPMC7412025 | biostudies-literature
| S-EPMC4136327 | biostudies-literature
| S-EPMC11319637 | biostudies-literature
| S-EPMC3705622 | biostudies-literature
| S-EPMC2386537 | biostudies-literature